MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41588-021-00928-6

Медицинская библиотека · Nature genetics · 2021

Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence.

Moody Sarah, Senkin Sergey, Islam S M Ashiqul, Wang Jingwei, Nasrollahzadeh Dariush, Cortez Cardoso Penha Ricardo, Fitzgerald Stephen, Bergstrom Erik N, Atkins Joshua, He Yudou, Khandekar Azhar, Smith-Byrne Karl, Carreira Christine, Gaborieau Valerie, Latimer Calli, Thomas Emily, Abnizova Irina, Bucciarelli Pauline E, Jones David, Teague Jon W, Abedi-Ardekani Behnoush, Serra Stefano, Scoazec Jean-Yves, Saffar Hiva, Azmoudeh-Ardalan Farid, Sotoudeh Masoud, Nikmanesh Arash, Poustchi Hossein, Niavarani Ahmadreza, Gharavi Samad, Eden Michael, Richman Paul, Campos Lia S, Fitzgerald Rebecca C, Ribeiro Luis Felipe, Soares-Lima Sheila Coelho, Dzamalala Charles, Mmbaga Blandina Theophil, Shibata Tatsuhiro, Menya Diana, Goldstein Alisa M, Hu Nan, Malekzadeh Reza, Fazel Abdolreza, McCormack Valerie, McKay James, Perdomo Sandra, Scelo Ghislaine, Chanudet Estelle, Humphreys Laura, Alexandrov Ludmil B, Brennan Paul, Stratton Michael R

СтатьяПоддержка NIH: внешняя программаResearch Support, N.I.H., IntramuralПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Esophageal squamous cell carcinoma (ESCC) shows remarkable variation in incidence that is not fully explained by known lifestyle and environmental risk factors. It has been speculated that an unknown exogenous exposure(s) could be responsible. Here we combine the fields of mutational signature analysis with cancer epidemiology to study 552 ESCC genomes from eight countries with varying incidence rates. Mutational profiles were similar across all countries studied. Associations between specific mutational signatures and ESCC risk factors were identified for tobacco, alcohol, opium and germline variants, with modest impacts on mutation burden. We find no evidence of a mutational signature indicative of an exogenous exposure capable of explaining differences in ESCC incidence. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC)-associated mutational signatures single-base substitution (SBS)2 and SBS13 were present in 88% and 91% of cases, respectively, and accounted for 25% of the mutation burden on average, indicating that APOBEC activation is a crucial step in ESCC tumor development.

Для цитирования: Moody Sarah, Senkin Sergey, Islam S M Ashiqul, Wang Jingwei, Nasrollahzadeh Dariush, Cortez Cardoso Penha Ricardo, Fitzgerald Stephen, Bergstrom Erik N, Atkins Joshua, He Yudou, Khandekar Azhar, Smith-Byrne Karl, Carreira Christine, Gaborieau Valerie, Latimer Calli, Thomas Emily, Abnizova Irina, Bucciarelli Pauline E, Jones David, Teague Jon W, Abedi-Ardekani Behnoush, Serra Stefano, Scoazec Jean-Yves, Saffar Hiva, Azmoudeh-Ardalan Farid, Sotoudeh Masoud, Nikmanesh Arash, Poustchi Hossein, Niavarani Ahmadreza, Gharavi Samad, Eden Michael, Richman Paul, Campos Lia S, Fitzgerald Rebecca C, Ribeiro Luis Felipe, Soares-Lima Sheila Coelho, Dzamalala Charles, Mmbaga Blandina Theophil, Shibata Tatsuhiro, Menya Diana, Goldstein Alisa M, Hu Nan, Malekzadeh Reza, Fazel Abdolreza, McCormack Valerie, McKay James, Perdomo Sandra, Scelo Ghislaine, Chanudet Estelle, Humphreys Laura, Alexandrov Ludmil B, Brennan Paul, Stratton Michael R. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence.. Nature genetics. 2021. DOI: 10.1038/s41588-021-00928-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.